
About Snibe
Snibe is a publicly listed company based in Shenzhen (China) founded in 1995. The company has 19 employees. Its chief executive, as recorded, is Rao Wei. Its Indian entity Snibe Diagnostic (India) Private Limited reported revenue of βΉ156 Cr. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Diversified.
Company details
Developer of laboratory analysis equipment and reagents. It offers clinical laboratory instruments and in vitro diagnostic reagents which include Immunoassay, Biochemistry, Electrolyte, molecular diagnostics, and lab automation integrated system. The lead product MAGLUMI CLIA system delivers fully automated, high-throughput diagnostic testing of multiple pathogens.
- Indian entity revenue₹156 Cr
FY 2025 · +70% YoY
- Indian entity net loss-₹1.61 Cr
FY 2025 · -1% margin
- Indian entity EBITDA-₹3.9 Lakh
FY 2025 · 0% margin
- Employee Count19
Associated legal entities of Snibe
Snibe operates through Snibe Diagnostic (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Snibe Diagnostic (India) Private Limited CIN U74999HR2018FTC075069 | Active | 20 Jul 2018 | Gurgaon, Haryana | ₹156 Cr | 19 | 4 | View details |
Apps and channels of Snibe
its YouTube channel Snibe Diagnostic has 3.44K subscribers and 30 videos.
Videos from Snibe
The most watched videos on Snibe's YouTube channel, Snibe Diagnostic (3.44K subscribers). Click a video to play it here.
More on Snibe Diagnostic.
Board of directors of Snibe Diagnostic (India) Private Limited (Snibe)
Snibe Diagnostic (India) Private Limited is the primary company behind Snibe. The board of Snibe Diagnostic (India) Private Limited currently have 3 directors; the longest-serving is Lei Zhang, appointed in 2018. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Lei Zhang DIN 08184326 | Director | 20 Jul 2018 | 8 yrs 4 mo | Snibe Diagnostic (India) Private Limited |
| Haiyan Liu DIN 08184327 | Director | 20 Jul 2018 | 8 yrs 4 mo | Snibe Diagnostic (India) Private Limited |
| Anand Prakash Kushwaha DIN 08262119 | Director | 20 Oct 2018 | 8 yrs | Snibe Diagnostic (India) Private Limited |
People of Snibe
3 people are tracked at Snibe (3 in leadership); the tracked headcount is 19.
| Name | Role | Group |
|---|---|---|
Efe Sullivan Naibe | Owner | Leadership |
Rao Wei | CEO & Managing Director | Leadership |
Lisa Fu | General Manager-uzbekistan | Leadership |
Complete people profiles for Snibe
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Snibe
Snibe is a publicly listed company on the SZSE with ticker symbol 300832 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date12 May 2020
- Listed onSZSE: 300832
- Listed entityShenzhen New Industries Biomedical Engineering Co. Ltd. Class A
- Exchange sectorHealth technology
- ISINCNE100003T39
- Share price52.76 CNY (+1.36% on the day) · 2026-10-14
- Market capitalisation40,847,710,974.00 CNY
- Price to earnings24.1
- EPS (diluted, trailing year)2.19 CNY
- Dividend yield2.31%
- Volume (last session)5,808,440
Financials of Snibe
Figures of Snibe Diagnostic (India) Private Limited, the primary company behind Snibe, for FY 2025. Revenue was ₹156 Cr (+70% year on year). Net loss was -₹1.61 Cr (-1% margin). EBITDA was -₹3.9 Lakh (0% margin). Revenue has grown at a compounded annual rate of +41% over three years and +138% over five years.
- ₹156 CrRevenue · FY 2025 · +70% YoY
- -₹1.61 CrNet loss · -1% margin
- -₹3.9 LakhEBITDA · 0% margin
- ₹5.00 CrPaid-up capital
- 19Employees (provident fund records)
- +41%Revenue CAGR, 3 years
- +138%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 4.53B CNY | 1.62B CNY | 1.99B CNY |
| 2024 | 4.53B CNY | 1.83B CNY | 2.15B CNY |
| 2023 | 3.92B CNY | 1.65B CNY | 1.92B CNY |
| 2022 | 3.04B CNY | 1.33B CNY | 1.46B CNY |
| 2021 | 2.54B CNY | 973.7M CNY | 1.17B CNY |
Balance sheet, profit and loss, cash flow and ratios of Snibe Diagnostic (India) Private Limited are on its company page.
Detailed financial statements for Snibe
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Snibe
The website of Snibe (snibe.com) receives about 6.4K visits a month.
- Monthly visits6.4K
▲ 6.7% vs previous month
Websites whose visitors overlap most with Snibe. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
stago-us.com | stago-us.com | 100% | #2,145,270 | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Snibe
Complete news archive for Snibe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Snibe
Snibe was founded in 1995.
Snibe is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
Rao Wei is the CEO of Snibe, as recorded in our data.
Snibe has 19 employees.
The primary company behind Snibe, Snibe Diagnostic (India) Private Limited, reported revenue of βΉ156 Cr for FY 2025, up 70% year on year.
Developer of laboratory analysis equipment and reagents. It offers clinical laboratory instruments and in vitro diagnostic reagents which include Immunoassay, Biochemistry, Electrolyte, molecular diagnostics, and lab automation integrated system. The lead product MAGLUMI CLIA system delivers fully automated, high-throughput diagnostic testing of multiple pathogens.
Yes, Snibe is publicly traded on SZSE under the ticker symbol 300832.
Snibe operates through Snibe Diagnostic (India) Private Limited.
The legal entities of Snibe currently have 4 directors, including Lei Zhang, Haiyan Liu, Anand Prakash Kushwaha and others.
